PTEN signaling in autism spectrum disorders

Current Opinion in Neurobiology

Volumn 22, Issue 5, 2012, Pages 873-879

  Zhou, Jing ^a   Parada, Luis F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

AUTISM; ENZYME ACTIVITY; GENE MUTATION; GERM LINE; HUMAN; MACROCEPHALY; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR;

BRAIN; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; MEMBRANE PROTEINS; MUTATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84868198811     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2012.05.004     Document Type: Review

References (55)

1. Sansal I., Sellers W.R. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004, 22:2954-2963.
2. Blumenthal G.M., Dennis P.A. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008, 16:1289-1300.
3. Endersby R., Baker S.J. PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 2008, 27:5416-5430.
4. Bertrand J., Mars A., Boyle C., Bove F., Yeargin-Allsopp M., Decoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001, 108:1155-1161.
5. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003, 33:365-382.
6. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003, 289:49-55.
7. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355.
8. Aman M.G., Langworthy K.S. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 2000, 30:451-459.
9. Malow B.A. Sleep disorders, epilepsy, and autism. Ment Retard Dev Disabil Res Rev 2004, 10:122-125.
10. Jyonouchi H., Geng L., Ruby A., Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51:77-85.
11. Valicenti-McDermott M., McVicar K., Rapin I., Wershil B.K., Cohen H., Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 2006, 27(Suppl.):S128-S136.
12. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry 2007, 16:61-66.
13. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., Miles J.H., Wang C.H., Stratton R., Pilarski R., Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005, 42:318-321.
14. Lainhart J.E., Piven J., Wzorek M., Landa R., Santangelo S.L., Coon H., Folstein S.E. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 1997, 36:282-290.
15. Fidler D.J., Bailey J.N., Smalley S.L. Macrocephaly in autism and other pervasive developmental disorders. Dev Med Child Neurol 2000, 42:737-740.
16. Zori R.T., Marsh D.J., Graham G.E., Marliss E.B., Eng C. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1998, 80:399-402.
17. Parisi M.A., Dinulos M.B., Leppig K.A., Sybert V.P., Eng C., Hudgins L. The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet 2001, 38:52-58.
18. Goffin A., Hoefsloot L.H., Bosgoed E., Swillen A., Fryns J.P. PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 2001, 105:521-524.
19. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., Li Y., Baker S.J., Parada L.F. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
20. Buxbaum J.D., Cai G., Chaste P., Nygren G., Goldsmith J., Reichert J., Anckarsater H., Rastam M., Smith C.J., Silverman J.M., et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B: Neuropsychiatr Genet 2007, 144B:484-491.
21. Herman G.E., Butter E., Enrile B., Pastore M., Prior T.W., Sommer A. Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly. Am J Med Genet A 2007, 143:589-593.
22. Lynch N.E., Lynch S.A., McMenamin J., Webb D. Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay. Arch Dis Child 2009, 94:553-554.
23. Orrico A., Galli L., Buoni S., Orsi A., Vonella G., Sorrentino V. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet 2009, 75:195-198.
24. Varga E.A., Pastore M., Prior T., Herman G.E., McBride K.L. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009, 11:111-117.
25. McBride K.L., Varga E.A., Pastore M.T., Prior T.W., Manickam K., Atkin J.F., Herman G.E. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res 2010, 3:137-141.
26. Stein M.T., Elias E.R., Saenz M., Pickler L., Reynolds A. Autistic spectrum disorder in a 9-year-old girl with macrocephaly. J Dev Behav Pediatr 2010, 31:632-634.
27. Redfern R.E., Daou M.C., Li L., Munson M., Gericke A., Ross A.H. A mutant form of PTEN linked to autism. Protein Sci 2010, 19:1948-1956.
28. Rodriguez-Escudero I., Oliver M.D., Andres-Pons A., Molina M., Cid V.J., Pulido R. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes. Hum Mol Genet 2011, 20:4132-4142.
29. Backman S.A., Stambolic V., Suzuki A., Haight J., Elia A., Pretorius J., Tsao M.S., Shannon P., Bolon B., Ivy G.O., Mak T.W. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 2001, 29:396-403.
30. Kwon C.H., Zhu X., Zhang J., Knoop L.L., Tharp R., Smeyne R.J., Eberhart C.G., Burger P.C., Baker S.J. Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 2001, 29:404-411.
31. Groszer M., Erickson R., Scripture-Adams D.D., Lesche R., Trumpp A., Zack J.A., Kornblum H.I., Liu X., Wu H. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 2001, 294:2186-2189.
32. Chow L.M., Endersby R., Zhu X., Rankin S., Qu C., Zhang J., Broniscer A., Ellison D.W., Baker S.J. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell 2011, 19:305-316.
33. Jaworski J., Spangler S., Seeburg D.P., Hoogenraad C.C., Sheng M. Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 2005, 25:11300-11312.
34. Jiang H., Guo W., Liang X., Rao Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 2005, 120:123-135.
35. Luikart B.W., Schnell E., Washburn E.K., Bensen A.L., Tovar K.R., Westbrook G.L. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 2011, 31:4345-4354.
36. Gregorian C., Nakashima J., Le Belle J., Ohab J., Kim R., Liu A., Smith K.B., Groszer M., Garcia A.D., Sofroniew M.V., et al. Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci 2009, 29:1874-1886.
37. Bonaguidi M.A., Wheeler M.A., Shapiro J.S., Stadel R.P., Sun G.J., Ming G.L., Song H. In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Cell 2011, 145:1142-1155.
38. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
39. Gartner A., Huang X., Hall A. Neuronal polarity is regulated by glycogen synthase kinase-3 (GSK-3beta) independently of Akt/PKB serine phosphorylation. J Cell Sci 2006, 119(Pt 19):3927-3934.
40. Hur E.M., Zhou F.Q. GSK3 signalling in neural development. Nat Rev Neurosci 2010, 11:539-551.
41. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
42. Kwiatkowski D.J., Manning B.D. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005, 14:R251-R258. Spec No. 2.
43. Wiznitzer M. Autism and tuberous sclerosis. J Child Neurol 2004, 19:675-679.
44. Meikle L., Talos D.M., Onda H., Pollizzi K., Rotenberg A., Sahin M., Jensen F.E., Kwiatkowski D.J. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci 2007, 27:5546-5558.
45. Tavazoie S.F., Alvarez V.A., Ridenour D.A., Kwiatkowski D.J., Sabatini B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 2005, 8:1727-1734.
46. Kishi M., Pan Y.A., Crump J.G., Sanes J.R. Mammalian SAD kinases are required for neuronal polarization. Science 2005, 307:929-932.
47. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
48. Zeng L.H., Rensing N.R., Zhang B., Gutmann D.H., Gambello M.J., Wong M. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 2011, 20:445-454.
49. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., Ramesh V., Silva A.J. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008, 14:843-848.
50. Ehninger D., Silva A.J. Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis. Behav Genet 2011, 41:357-363.
51. Zhou J., Blundell J., Ogawa S., Kwon C.H., Zhang W., Sinton C., Powell C.M., Parada L.F. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009, 29:1773-1783.
52. Courchesne E., Pierce K., Schumann C.M., Redcay E., Buckwalter J.A., Kennedy D.P., Morgan J. Mapping early brain development in autism. Neuron 2007, 56:399-413.
53. Penzes P., Cahill M.E., Jones K.A., VanLeeuwen J.E., Woolfrey K.M. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 2011, 14:285-293.
54. O'Roak B.J., Deriziotis P., Lee C., Vives L., Schwartz J.J., Girirajan S., Karakoc E., Mackenzie A.P., Ng S.B., Baker C., et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011, 43:585-589.
55. Page D.T., Kuti O.J., Prestia C., Sur M. Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A 2009, 106:1989-1994.